Riskpilot← Back to searchSign inGet full accessAmbolt Health ApS
APSActiveCVR 39662442Slotsgade 27, 2.Computer consultancy and computer facilities management activities · NACE 6220Est. 20185 employees
Revenue 2024
DKK 6,3M
-10% vs 2023
EBITDA margin
36.3%
-14% vs 2023
Equity ratio
64.0%
Financial strength
Net profit 2024
DKK 1,7M
-12% vs 2023
| Revenue | DKK 6,3M | -10% |
| EBITDA | DKK 2,3M | -14% |
| Net profit | DKK 1,7M | -12% |
| Total assets | DKK 3,3M | -5% |
| Equity | DKK 2,1M | -7% |
| Employees | 5 | — |
Legal name
Ambolt Health ApS
CVR number
39662442
Legal form
Anpartsselskab
NACE code
6220 · Computer consultancy and computer facilities management activities
Founded
22. juni 2018
Share capital
DKK 40.000
Employees
5 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af den samlede direktion.
Company purpose
Selskabets formål er at drive konsulenthus samt udvikle softwareprodukter samt anden dermed efter direktionens skøn beslægtet virksomhed.
Address
Slotsgade 27, 2.
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | -12 | 2.757 | 7.576 | 6.953 | 6.262 |
| Staff expenses | -0 | -2.387 | -4.142 | -4.311 | -3.991 |
| EBITDA | -12 | 371 | 3.434 | 2.641 | 2.272 |
| Depreciation & amort. | -0 | -61 | -105 | -105 | -44 |
| EBIT | -12 | 309 | 3.329 | 2.537 | 2.228 |
| Net financials | -3 | 6 | -9 | -11 | -6 |
| Profit before tax | -14 | 316 | 3.321 | 2.525 | 2.222 |
| Tax | -0 | 62 | 731 | 556 | 489 |
| Net profit | -14 | 253 | 2.590 | 1.970 | 1.733 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 875 | 2.084 | 4.068 | 3.463 | 3.278 |
| Equity | -48 | 206 | 2.795 | 2.265 | 2.099 |
| Long-term debt | 0 | 189 | 191 | 202 | 208 |
| Short-term debt | 923 | 1.689 | 1.082 | 996 | 971 |
| Total debt | 923 | 1.878 | 1.273 | 1.198 | 1.179 |
EBITDA margin
36.3%
This company
15.8%
Market median
+130% vs market
20202024
Equity ratio
64.0%
This company
38.2%
Market median
+68% vs market
20202024
Return on equity
82.6%
This company
18.4%
Market median
+349% vs market
20202024
Net profit margin
27.7%
This company
8.1%
Market median
+242% vs market
20202024
Asset turnover
1.91×
This company
1.12×
Market median
+71% vs market
20202024
Debt / equity
0.56×
This company
0.62×
Market median
+10% vs market
20202024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
AB Management | Management | 2018 |
SP Management | Management | 2020 |
| Former (2) | ||
MM Management | Management | 2018 – 2020 |
KM Management | Management | 2018 – 2020 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2018 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
SingaSpar ApS
Ambolt Health ApS Board members of Ambolt Health ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mathias Meldgaard Andersen | Management | 0 companies |
| Kent Munthe Caspersen | Management | 0 companies |
| Andreas Berre Eriksen | Management | 0 companies |
| Steen Palle Petersen | Management | 0 companies |